AppScript

A platform for pragmatic research and to drive uptake of Digital Therapeutics

To strengthen your value proposition in the market, more and more life sciences companies are enhancing their offerings by including digital therapeutics (DTx) as digital companions for patients. Supporting new models of care will strengthen your position in the market and drive innovation.

What is AppScript?

Electronic Health Record Integrated App Prescribing and Monitoring Tool
It enables healthcare professionals to prescribe Apps within their workflows and has the ability to get utilisation metrics on prescription rates, fill rates by app types and region.

A Clinical Study Management Tool
AppScript® One Click Studies, enables patient recruitment into studies, with data export & linkage functionality.

A digital health app library
Each App on the library is assigned an AppScript Score.  A living score comprised of six individual rating categories measuring key App quality indicators.

Why use AppScript?

Life sciences companies have already been commercialising digital companions for a wide variety of disease areas, including respiratory diseases, mental health, diabetes, oncology and gastrointestinal diseases.

AppScript helps pharma and digital therapeutics overcome their three main challenges: patient enrolment, uptake and monitoring.
AppScript enables the success of the partnership between pharma and digital therapeutic by proving the value of the app as a digital companion in a specific disease area.
AppScript’s web portal (AppScript.net) enables scalability, fostering a faster roll-out and acts as a central distribution channel for digital health solutions.

 

In primary care, AppScript is embedded into all EMIS sites in England. 58% of all GP practices in England have access to AppScript directly from within their EMR.
In secondary care, the AppScript.net portal can be used by clinicians, to prescribe digital therapeutics and track patient uptake.
41 partnerships already exist between pharma and digital therapeutics, to improve clinical and health economic outcomes.

Institute Report: Digital Health Trends 2021

This study of digital health covers trends in four areas — innovation, evidence, regulation, and adoption — to assess how these new tools are becoming an entirely new therapeutic modality alongside traditional medicines and medical devices.
Nurse with baby delivery room

Market Intelligence Solutions

Powered by IQVIA's Information Offerings, our healthcare market intelligence solutions provides key summary data and actionable insights covering medicines and healthcare products in primary care, secondary care and supply chains across the UK, NHS and healthcare sectors. 
Medical app icon on smart watch screen

Digital therapeutics

In collaboration with EMIS Health, IQVIA launched the EMIS App Library by AppScript, enabling more than half of GP surgeons in England to to recommend apps to millions of patients.

By fully appreciating and leveraging clinicians’ real world activity, we accomplish our vision of Human Data Science, where every clinical decision can be made based on credible and robust evidence. This technology has the potential to drive significant cost savings for the NHS through improved prevention and management of chronic conditions and support the delivery of clinical research goals as set out in the NHS Long Term Plan, contributing to make the NHS the world’s most advanced primary healthcare system with respect to the delivery of digitally enabled care.

Contact Us